D2-40-positive lymphatic vessel invasion is not a poor prognostic factor in stage I lung adenocarcinoma

Pathology International

Volumn 63, Issue 4, 2013, Pages 201-205

  Shimizu, Kei ^a   Funai, Kazuhito ^a   Sugimura, Haruhiko ^a   Sekihara, Keigo ^a   Kawase, Akikazu ^a   Shiiya, Norihiko ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

D2 40 immunostaining; Elastica van Gieson; Hematoxylin Eosin; Lung adenocarcinoma; Lymphatic vessel invasion; Prognostic factor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FEMALE; HUMANS; JAPAN; LUNG NEOPLASMS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84878118469     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12048     Document Type: Article

References (21)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Sawabata N, Asamura H, Goya T etal. Japanese Lung Cancer Registry Study: First prospective enrollment of a large number of surgical and nonsurgical cases in 2002. J Thorac Oncol 2010; 5: 1369-1375.
3. Iwakoshi A, Murakumo Y, Kato T etal. RET finger protein expression is associated with prognosis in lung cancer with epidermal growth factor receptor mutations. Pathol Int 2012; 62: 324-330.
4. Goldstraw P. Stageing Manual in Thoracic Oncology. Denver: IASLC, 2009.
5. Gabor S, Renner H, Popper H etal. Invasion of blood vessels significant prognostic factor in radically resected T1-3N0M0 non-small-cell lung cancer. Eur J Cardiothorac Surg 2004; 25: 439-442.
6. Urabe A, Matsumoto T, Kimura M, Sonoue H, Kinoshita K. Grading system of lymphatic invasion according to D2-40 immunostaining is useful for the prediction of nodal metastasis in squamous cell carcinoma of the uterine cervix. Histopathology 2006; 49: 493-497.
7. Walgenbach-Bruenagel G, Tolba RH, Varnai AD, Bollmann M, Hirner A, Walgenbach KJ. Detection of lymphatic invasion in early stage primary colorectal cancer with the monoclonal antibody D2-40. Eur Surg Res 2006; 38: 438-444.
8. Van den Eynden GG, Van der Auwera I, Van Laere SJ etal. Distinguishing blood and lymph vessel invasion in breast cancer: A prospective immunohistochemical study. Br J Cancer 2006; 94: 1643-1649.
9. Yonemura Y, Endou Y, Tabachi K etal. Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40. Hum Pathol 2006; 37: 1193-1199.
10. Kadota K, Huang CL, Liu D etal. The clinical significance of the tumor cell D2-40 immunoreactivity in non-small cell lung cancer. Lung Cancer 2010; 70: 88-93.
11. Min KH, Park SJ, Lee KS etal. Clinical usefulness of D2-40 in non-small cell lung cancer. Lung 2011; 189: 57-63.
12. Funai K, Sugimura H, Morita T, Shundo Y, Shimizu K, Shiiya N. Lymphatic vessel invasion is a significant prognostic indicator in stage IA lung adenocarcinoma. Ann Surg Oncol 2011; 18: 2968-2972.
13. Travis WD, Brambilla E, Muller-Hermelink H, Harris CC. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004.
14. Travis WD, Brambilla E, Noguchi M etal. International Association for the Study of Lung Cancer/American Thoracic Society/ European Respiratory Society International multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6: 244-285.
15. Igarashi H, Sugimura H, Maruyama K etal. Alteration of immunoreactivity by hydrated autoclaving, microwave treatment, and simple heating of paraffin-embedded tissue sections. APMIS 1994; 102: 295-307.
16. Bréchot JM, Chevret S, Charpentier MC etal. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival. Cancer 1996; 78: 2111-2118.
17. Kahn HJ, Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 2002; 82: 1255-1257.
18. Iwakiri S, Nagai S, Katakura H etal. D2-40-positive lymphatic vessel density is a poor prognostic factor in squamous cell carcinoma of the lung. Ann Surg Oncol 2009; 16: 1678-1685.
19. Faoro L, Hutto JY, Salgia R etal. Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma. Arch Pathol Lab Med 2008; 132: 1882-1888.
20. Inoue M, Takakuwa T, Minami M etal. Clinicopathologic factors influencing postoperative prognosis in patients with small-sized adenocarcinoma of the lung. J Thorac Cardiovasc Surg 2008; 135: 830-836.
21. Hashizume S, Nagayasu T, Hayashi T etal. Accuracy and prognostic impact of a vessel invasion grading system for stage IA non-small cell lung cancer. Lung Cancer 2009; 65: 363-370.